By competitively inhibiting the adsorption of plasminogen on the fibrin network, plasminogen activation is reduced, thereby preventing fibrin degradation and bleeding.

Tranexamic acid competitively inhibits the adsorption of plasminogen on the fibrin network, reduces the activation of plasminogen, thereby inhibiting the production of plasmin, preventing the formation of fibrin degradation products and the dissolution of blood clots and bleeding.

Extract from the above information

This product is a potent and highly selective competitive antagonist of 5-hydroxytryptamine 3 (5-HT3) receptors in peripheral neurons and the central nervous system. It inhibits the vomiting reflex mainly by selectively blocking the presynaptic 5-HT3 receptors of peripheral neurons. Its antiemetic effect may also be related to its inhibition of the stimulation of the vagus nerve in the rear region by directly blocking the central 5-HT3 receptors.